Provided by Tiger Fintech (Singapore) Pte. Ltd.

Insmed

103.09
-1.0800-1.04%
Volume:527.27K
Turnover:54.46M
Market Cap:19.56B
PE:-17.51
High:105.01
Open:105.01
Low:102.47
Close:104.17
Loading ...

Will Insmed Incorporated’s (INSM) New Drugs be Able to Peak Sales?

Insider Monkey
·
19 Feb

Insmed Is Maintained at Overweight by Wells Fargo

Dow Jones
·
19 Feb

Insmed Incorporated : Wells Fargo Raises Target Price to $107 From $85

THOMSON REUTERS
·
19 Feb

Mizuho Adjusts Price Target on Insmed to $96 From $88, Keeps Outperform Rating

MT Newswires Live
·
18 Feb

Will These 5 Biotech Stocks Surpass Q4 Earnings Forecast?

Zacks
·
17 Feb

Countdown to Insmed (INSM) Q4 Earnings: Wall Street Forecasts for Key Metrics

Zacks
·
17 Feb

Insmed (INSM) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release

Zacks
·
13 Feb

Insmed Is Maintained at Buy by Stifel

Dow Jones
·
11 Feb

Stifel Nicolaus Remains a Buy on Insmed (INSM)

TIPRANKS
·
11 Feb

Analysts Offer Insights on Healthcare Companies: Cytokinetics (CYTK), Insmed (INSM) and IQVIA Holdings (IQV)

TIPRANKS
·
11 Feb

Insmed to Host Fourth-Quarter and Full-Year 2024 Financial Results Conference Call on Thursday, February 20, 2025

PR Newswire
·
10 Feb

Have Insiders Sold Insmed Shares Recently?

Simply Wall St.
·
09 Feb

Massive Insider Stock Sell-Off at Insmed: What You Need to Know!

TIPRANKS
·
08 Feb

Insmed Is Maintained at Buy by Guggenheim

Dow Jones
·
08 Feb

Insmed's NDA for Lung Disease Drug Gets FDA's Priority Review

Zacks
·
07 Feb

Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

PR Newswire
·
07 Feb

Truist Financial Sticks to Their Buy Rating for Insmed (INSM)

TIPRANKS
·
07 Feb

Insmed price target raised to $92 from $83 at JPMorgan

TIPRANKS
·
07 Feb

U.S. RESEARCH ROUNDUP-Altus Power, Amazon, Nevro

Reuters
·
07 Feb

Mizuho Securities Reaffirms Their Buy Rating on Insmed (INSM)

TIPRANKS
·
07 Feb